New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study estimates. But experts urge caution.

Today, as part of a national initiative funded by The John A. Hartford Foundation (JAHF), the national, independent nonprofit FAIR Health launched a new shared decision-making tool for Alzheimer's ...

Navigating the challenges of an early-onset Alzheimer's diagnosis? This guide covers financial and legal considerations.

In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from ...

New drug approvals and a federal dementia care pilot program among the year's significant developments, according to the nonprofit.

Doctors and aging experts say early intervention is key. When dementia is diagnosed early on, there are more treatment and ...

An assisted living facility with distinguished Alzheimer’s disease and dementia care in Aurora has received national ...

In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from clinical trials showing that both drugs slowed the progression of the disease.

New research comparing different approaches to dementia care for people with Alzheimer's disease and other dementias found no significant differences in patient behavioral symptoms or caregiver strain ...

In a heartwarming display of community spirit, Peter Bentley, the dedicated maintenance man at Coverage Care’s Greenfields ...

Joanna Paladino, MD, and colleagues identified four themes that may improve the delivery of a dementia diagnosis for clinicians, patients, and caregivers.